182 related articles for article (PubMed ID: 24816861)
1. Association of mTOR polymorphisms with cancer risk and clinical outcomes: a meta-analysis.
Shao J; Li Y; Zhao P; Yue X; Jiang J; Liang X; He X
PLoS One; 2014; 9(5):e97085. PubMed ID: 24816861
[TBL] [Abstract][Full Text] [Related]
2. Impacts of the mTOR gene polymorphisms rs2536 and rs2295080 on breast cancer risk in the Chinese population.
Zhao Y; Diao Y; Wang X; Lin S; Wang M; Kang H; Yang P; Dai C; Liu X; Liu K; Li S; Zhu Y; Dai Z
Oncotarget; 2016 Sep; 7(36):58174-58180. PubMed ID: 27533457
[TBL] [Abstract][Full Text] [Related]
3. Associations of genetic polymorphisms in pTEN/AKT/mTOR signaling pathway genes with cancer risk: A meta-analysis in Asian population.
Zhang Z; Chen Q; Zhang J; Wang Y; Hu X; Yin S; He M; Guan S; Qin W; Xiao Q; Zhao H; Yao W; Wu H; Wei M
Sci Rep; 2017 Dec; 7(1):17844. PubMed ID: 29259266
[TBL] [Abstract][Full Text] [Related]
4. Comprehensive analysis of the effect of rs2295080 and rs2536 polymorphisms within the mTOR gene on cancer risk.
Qi GH; Wang CH; Zhang HG; Yu JG; Ding F; Song ZC; Xia QH
Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32597485
[TBL] [Abstract][Full Text] [Related]
5. Genetic polymorphisms of mTOR and cancer risk: a systematic review and updated meta-analysis.
Zining J; Lu X; Caiyun H; Yuan Y
Oncotarget; 2016 Aug; 7(35):57464-57480. PubMed ID: 27462867
[TBL] [Abstract][Full Text] [Related]
6. Associations of Genetic Polymorphisms of mTOR rs2295080 T/G and rs1883965 G/A with Susceptibility of Urinary System Cancers.
Min Z; Mi Y; Lv Z; Sun Y; Tang B; Wu H; Zhang Z; Pan H; Zhang Y; Lu C; Zuo L; Zhang L
Dis Markers; 2022; 2022():1720851. PubMed ID: 35082928
[TBL] [Abstract][Full Text] [Related]
7. Functional variant of MTOR rs2536 and survival of Chinese gastric cancer patients.
Cheng L; Qiu L; Zhang R; Qian D; Wang M; Sun M; Zhu X; Wang Y; Guo W; Wei Q
Int J Cancer; 2019 Jan; 144(2):251-262. PubMed ID: 29978580
[TBL] [Abstract][Full Text] [Related]
8. Association of genetic variants in lncRNA GAS5/miR-21/mTOR axis with risk and prognosis of coronary artery disease among a Chinese population.
Li H; Liu Y; Huang J; Liu Y; Zhu Y
J Clin Lab Anal; 2020 Oct; 34(10):e23430. PubMed ID: 32557866
[TBL] [Abstract][Full Text] [Related]
9. Polymorphisms in the mTOR gene and risk of sporadic prostate cancer in an Eastern Chinese population.
Li Q; Gu C; Zhu Y; Wang M; Yang Y; Wang J; Jin L; Zhu ML; Shi TY; He J; Zhou X; Ye DW; Wei Q
PLoS One; 2013; 8(8):e71968. PubMed ID: 23940798
[TBL] [Abstract][Full Text] [Related]
10. Functional promoter rs2295080 T>G variant in MTOR gene is associated with risk of colorectal cancer in a Chinese population.
Xu M; Gao Y; Yu T; Wang J; Cheng L; Cheng L; Cheng D; Zhu B
Biomed Pharmacother; 2015 Mar; 70():28-32. PubMed ID: 25776475
[TBL] [Abstract][Full Text] [Related]
11. Meta-analysis of the association between mTORC1-related genes polymorphisms and cancer risk.
Lu X; Liu M; Liao Y; Huang C; Chai L; Jin Y; Xiong Q; Chen B
Pathol Res Pract; 2022 Jan; 229():153696. PubMed ID: 34839094
[TBL] [Abstract][Full Text] [Related]
12. Associations of PI3KR1 and mTOR polymorphisms with esophageal squamous cell carcinoma risk and gene-environment interactions in Eastern Chinese populations.
Zhu J; Wang M; Zhu M; He J; Wang JC; Jin L; Wang XF; Xiang JQ; Wei Q
Sci Rep; 2015 Feb; 5():8250. PubMed ID: 25654238
[TBL] [Abstract][Full Text] [Related]
13. Association of genetic variations in mTOR with risk of childhood acute lymphoblastic leukemia in a Chinese population.
Huang L; Huang J; Wu P; Li Q; Rong L; Xue Y; Lu Q; Li J; Tong N; Wang M; Zhang Z; Fang Y
Leuk Lymphoma; 2012 May; 53(5):947-51. PubMed ID: 21973240
[TBL] [Abstract][Full Text] [Related]
14. [Association of mammalian target of rapamycin gene polymorphisms with the risk of pediatric epilepsy].
Yue X; Zhao PW; Liu ZS; Wu GF; Tu F; Hu JS; He XL
Zhongguo Dang Dai Er Ke Za Zhi; 2015 Jun; 17(6):560-4. PubMed ID: 26108313
[TBL] [Abstract][Full Text] [Related]
15. Association between five polymorphisms in vascular endothelial growth factor gene and urinary bladder cancer risk: A systematic review and meta-analysis involving 6671 subjects.
Song Y; Yang Y; Liu L; Liu X
Gene; 2019 May; 698():186-197. PubMed ID: 30849545
[TBL] [Abstract][Full Text] [Related]
16. A polymorphism (rs2295080) in mTOR promoter region and its association with gastric cancer in a Chinese population.
Xu M; Tao G; Kang M; Gao Y; Zhu H; Gong W; Wang M; Wu D; Zhang Z; Zhao Q
PLoS One; 2013; 8(3):e60080. PubMed ID: 23555892
[TBL] [Abstract][Full Text] [Related]
17. Association between KCNJ11 gene polymorphisms and risk of type 2 diabetes mellitus in East Asian populations: a meta-analysis in 42,573 individuals.
Yang L; Zhou X; Luo Y; Sun X; Tang Y; Guo W; Han X; Ji L
Mol Biol Rep; 2012 Jan; 39(1):645-59. PubMed ID: 21573802
[TBL] [Abstract][Full Text] [Related]
18. Genetic variations in a PTEN/AKT/mTOR axis and prostate cancer risk in a Chinese population.
Chen J; Shao P; Cao Q; Li P; Li J; Cai H; Zhu J; Wang M; Zhang Z; Qin C; Yin C
PLoS One; 2012; 7(7):e40817. PubMed ID: 22815832
[TBL] [Abstract][Full Text] [Related]
19. Effects of the mTOR and AKT genes polymorphisms on systemic lupus erythematosus risk.
Saravani M; Shahraki-Ghadimi H; Maruei-Milan R; Mehrabani M; Mirzamohammadi S; Nematollahi MH
Mol Biol Rep; 2020 May; 47(5):3551-3556. PubMed ID: 32319007
[TBL] [Abstract][Full Text] [Related]
20. Effects of the MTOR and AKT1 genes polymorphisms on papillary thyroid cancer development.
Maruei-Milan R; Saravani M; Heidari Z; Asadi-Tarani M; Salimi S
IUBMB Life; 2020 Dec; 72(12):2601-2610. PubMed ID: 33107190
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
